Embecta Corp. has finalized its acquisition of Owen Mumford Holdings Limited for an initial £100 million plus up to £50 million in performance-based payments. This deal enhances Embecta's transformation into a broad-based medical supplies company by adding Owen Mumford's drug delivery platforms, including the Aidaptus® auto-injector, and chronic care devices. The acquisition leverages Owen Mumford's design and manufacturing capabilities alongside Embecta's global commercial infrastructure, aiming to expand geographic reach and operational efficiencies. This strategic move positions Embecta to better serve pharmaceutical partners and chronic care patients across multiple therapeutic areas.
MasterCraft Boat Holdings has finalized its acquisition of Marine Products Corporation, adding the Chaparral and Robalo brands to its portfolio. This merger creates a diversified lineup of leading recreational marine brands, enhancing dealer networks...
The bond market now signals a Federal Reserve rate hike is more likely than not by December 2026, reversing earlier expectations of rate cuts. This shift comes amid strong economic data, including rising retail sales and inflation pressures driven by...
President Donald Trump insisted on a genuine 20-year nuclear activity ban from Iran and dismissed Iran's recent proposal as unacceptable. He emphasized that the U.S. does not seek favors from China regarding reopening the Strait of Hormuz, asserting ...
ESET announced that Chief Security Evangelist Tony Anscombe will co-chair and participate in a panel at the NetDiligence Cyber Risk Summit on May 19-20, 2026, in San Diego. The session will focus on emerging cyber risks beyond AI, including quantum c...
Metalla Royalty & Streaming Ltd. has nominated Sandeep Singh to its board of directors for election at the upcoming annual general meeting on June 23, 2026. Singh brings 20 years of experience in mining, royalties, and capital markets, currently serv...
